NCT03835663View on ClinicalTrials.gov

The Bacterial Composition of the Stomach in Reflux Disease

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 4, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
GORDOesophageal CancerOesophageal RefluxGastric CancerGastro Esophageal RefluxOesophageal CarcinomaBarrett EsophagusEsophagitis
Interventions
DIAGNOSTIC_TEST

No intervention but patients are undergoing an upper GI endoscopy and biopsies for clinical purposes

Standard upper GI endoscopy with biopsies

Trial Locations (1)

W2 1NY

Imperial College Healthcare, St Mary's Hospital, Paddington, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT03835663 - The Bacterial Composition of the Stomach in Reflux Disease | Biotech Hunter | Biotech Hunter